Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8681 |
High Similarity |
NPD1613 |
Approved |
0.8681 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8414 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8403 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8219 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8144 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8133 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8125 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8105 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8038 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8025 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7976 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7929 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7927 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7882 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.784 |
Intermediate Similarity |
NPD37 |
Approved |
0.7836 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7831 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7805 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7805 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7805 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7718 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7706 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7671 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7661 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7651 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7644 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7633 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7622 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7619 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7586 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.745 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7436 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7425 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7401 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7401 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7365 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7346 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7346 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7301 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7299 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7255 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7235 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7171 |
Intermediate Similarity |
NPD8651 |
Approved |
0.717 |
Intermediate Similarity |
NPD5588 |
Approved |
0.717 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7118 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7081 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7065 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7059 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7041 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7033 |
Intermediate Similarity |
NPD4663 |
Approved |
0.703 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7012 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7011 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7006 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.6993 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD5735 |
Approved |
0.6975 |
Remote Similarity |
NPD5762 |
Approved |
0.6975 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD5763 |
Approved |
0.6975 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6961 |
Remote Similarity |
NPD4578 |
Approved |
0.6961 |
Remote Similarity |
NPD4577 |
Approved |
0.6959 |
Remote Similarity |
NPD7157 |
Approved |
0.6959 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6957 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD5126 |
Approved |
0.6954 |
Remote Similarity |
NPD5846 |
Approved |
0.6954 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6951 |
Remote Similarity |
NPD3892 |
Phase 2 |
0.6951 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD3750 |
Approved |
0.6951 |
Remote Similarity |
NPD7466 |
Approved |
0.6944 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6933 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD7041 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD228 |
Approved |
0.6914 |
Remote Similarity |
NPD6100 |
Approved |
0.6914 |
Remote Similarity |
NPD6099 |
Approved |
0.6905 |
Remote Similarity |
NPD5403 |
Approved |
0.6902 |
Remote Similarity |
NPD7906 |
Approved |
0.6897 |
Remote Similarity |
NPD3021 |
Approved |
0.6897 |
Remote Similarity |
NPD3022 |
Approved |
0.6893 |
Remote Similarity |
NPD2489 |
Approved |
0.6893 |
Remote Similarity |
NPD27 |
Approved |
0.689 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6888 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6888 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD1357 |
Approved |
0.6886 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD3051 |
Approved |
0.6875 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6871 |
Remote Similarity |
NPD7843 |
Approved |
0.6868 |
Remote Similarity |
NPD7311 |
Approved |
0.6868 |
Remote Similarity |
NPD7310 |
Approved |
0.6868 |
Remote Similarity |
NPD7312 |
Approved |
0.6868 |
Remote Similarity |
NPD7313 |
Approved |
0.6863 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6859 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6855 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6852 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6848 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6846 |
Remote Similarity |
NPD6671 |
Approved |
0.6836 |
Remote Similarity |
NPD2970 |
Approved |
0.6836 |
Remote Similarity |
NPD2969 |
Approved |
0.6835 |
Remote Similarity |
NPD7095 |
Approved |
0.6831 |
Remote Similarity |
NPD7309 |
Approved |
0.6829 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6829 |
Remote Similarity |
NPD7037 |
Approved |
0.6828 |
Remote Similarity |
NPD2684 |
Approved |
0.6824 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6821 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD4140 |
Approved |
0.6813 |
Remote Similarity |
NPD1558 |
Phase 1 |
0.6811 |
Remote Similarity |
NPD6841 |
Approved |
0.6811 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6811 |
Remote Similarity |
NPD6842 |
Approved |
0.6807 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6807 |
Remote Similarity |
NPD2677 |
Approved |
0.6806 |
Remote Similarity |
NPD6779 |
Approved |
0.6806 |
Remote Similarity |
NPD6776 |
Approved |
0.6806 |
Remote Similarity |
NPD6782 |
Approved |
0.6806 |
Remote Similarity |
NPD6781 |
Approved |
0.6806 |
Remote Similarity |
NPD6780 |
Approved |
0.6806 |
Remote Similarity |
NPD6778 |
Approved |
0.6806 |
Remote Similarity |
NPD6777 |
Approved |
0.679 |
Remote Similarity |
NPD7119 |
Phase 2 |
0.6788
|
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |